BioNTech declares net profit of €2.05 billion

Another COVID-19 vaccine maker proves yet again that the vaccine is a great revenue generator.

An image of BioNTech’s COVID-19 vaccine
BioNTech’s COVID-19 vaccine

Business Stance is dedicated to ensuring that every Nigerian comfortably stays one step ahead with an in-depth view of the global financial markets.